Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22048371 | 1.00 | TSHR (0.59) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL20067041 | 1.00 | TSHR (0.59) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL12937820 | 0.97 | TSHR (0.56) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL223572 | 0.97 | — | — | |
| SCHEMBL4391161 | 0.94 | TSHR (0.59) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL455523 | 0.94 | TSHR (0.59) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL19412778 | 0.94 | TSHR (0.59) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL27304416 | 0.94 | — | — | |
| SCHEMBL5176669 | 0.94 | TSHR (0.59) | TSHRMEN1KMT2AHTTTHRB | |
| SCHEMBL4390855 | 0.92 | MEN1 (0.62) | TSHRMEN1KMT2AHTTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3694938-B1 | TIRE FOR VEHICLE WHEELS | PIRELLI (IT) | 2021-12-08 | — | — | EP | disclosed |
| EP-3694938-A1 | TIRE FOR VEHICLE WHEELS | Pirelli Tyre S.p.A. (IT) | 2020-08-19 | — | — | EP | disclosed |
| WO-2019073378-A1 | TIRE FOR VEHICLE WHEELS | PIRELLI TYRE S.P.A. (IT) | 2019-04-18 | — | — | WO | disclosed |
| EP-3004283-B1 | A LOW TEMPERATURE STABILIZED FOAM-FORMING COMPOSITION FOR ENHANCED OIL RECOVERY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-04 | — | — | EP | disclosed |
| WO-2014193731-A1 | A LOW TEMPERATURE STABILIZED FOAM-FORMING COMPOSITION FOR ENHANCED OIL RECOVERY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-12-04 | — | — | WO | disclosed |
| US-20130184243-A1 | COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF TREATING SKIN DISORDERS THEREWITH | CEPTARIS THERAPEUTICS, INC. (US) | 2013-07-18 | — | — | US | disclosed |
| WO-2013009800-A2 | COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF TREATING SKIN DISORDERS THEREWITH | CEPTARIS THERAPEUTICS, INC. (US) | 2013-01-17 | — | — | WO | disclosed |
| US-8173585-B2 | Acidic hard surface cleaning compositions | RECKITT BENCKISER (UK) LIMITED (GB) | 2012-05-08 | — | — | US | disclosed |
| US-20110112006-A1 | IMPROVEMENTS IN ACIDIC HARD SURFACE CLEANING COMPOSITIONS | RECKITT BENCKISER (UK) LIMITED (GB) | 2011-05-12 | — | — | US | disclosed |
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | MITSUI CHEMICALS, INC. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20030091931-A1 | Benzbisazole compound and optical recording medium containing the compound | MITSUI CHEMICALS, INC. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1245571-A1 | BENZBISAZOLE COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING THE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2002-10-02 | — | — | EP | disclosed |
| EP-1180765-A1 | Optical recording medium and porphycene compound | Mitsui Chemicals, Inc. (JP) | 2002-02-20 | — | — | EP | disclosed |
| EP-1152029-A1 | POLYBLEND COMPOSITION, CROSSLINKED OBJECT, AND HOSE FOR FUEL | NIPPON ZEON CO., LTD. (JP) | 2001-11-07 | — | — | EP | disclosed |
| EP-1055712-A2 | Aqueous ink for ink jet recording | Mitsui Chemicals, Inc. (JP) | 2000-11-29 | — | — | EP | disclosed |
| US-6106999-A | SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS | MITSUI CHEMICALS (JP) | 2000-08-22 | — | — | US | disclosed |
| EP-0084966-B1 | AQUEOUS COMPOSITIONS CONTAINING OVERBASED MATERIALS | The Lubrizol Corporation (US) | 1989-11-08 | — | — | EP | disclosed |
| EP-0330379-A2 | Cleansing compositions | The British Petroleum Company p.l.c. (GB) | 1989-08-30 | — | — | EP | disclosed |
| US-4468339-A | AND SOLUBILIZER WHICH IS REACTION OF CARBOXYLIC ACID ACYLATING AGENT WITH HYDROCARBON SUBSTITMENT AND HYDROXYAMINE | THE LUBRIZOL CORPORATION (US) | 1984-08-28 | — | — | US | disclosed |
| EP-0084966-A2 | Aqueous compositions containing overbased materials | The Lubrizol Corporation (US) | 1983-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | CACNA1B, KCNN4, KCNN2 | TSHR 3610/4885MEN1 979/4885KMT2A 3032/4885 |
| US-20030091931-A1 | Benzbisazole compound and optical recording medium containing the compound | DAO, CACNA1I, KCNB2 | TSHR 3514/4885MEN1 3290/4885KMT2A 2859/4885 |
| US-20130184243-A1 | COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF TREATING SKIN DISORDERS THEREWITH | MGMT, UNG, OGG1 | TSHR 4712/4885MEN1 1512/4885KMT2A 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.